TickerFacts.

Oaktree Acquisition Corp. III Life Sciences (OACC): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$6.77M
As of 2025-12-31
-$7.49M
As of 2026-06-30
2024-12-31: -$6.07M2025-12-31: -$6.77M-$6.77M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$6.77Mn/m2026-03-26, Balance as of period end
2024-12-31-$6.07Mn/a2026-03-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Oaktree Acquisition Corp. III Life Sciences (OACC)2025-12-31-$6.77Mn/m
Dynamix Corp III (DNMX)2025-12-31-$6.83Mn/a
Vendome Acquisition Corp I (VNME)2025-12-31$404.7Kn/a
Pyrophyte Acquisition Corp. II (PAII)2025-12-31-$8.67Mn/a
Axiom Intelligence Acquisition Corp 1 (AXIN)2025-12-31-$7.18Mn/a
Blue Acquisition Corp/Cayman (BACC)2025-12-31-$7.43Mn/a
Thayer Ventures Acquisition Corp II (TVAI)2025-12-31-$8.18Mn/m
Cantor Equity Partners I, Inc. (CEPO)2025-12-31-$16.78Mn/m
SilverBox Corp IV (SBXDF)2025-12-31-$12.83Mn/m

Compare OACC, DNMX, VNME, PAII side by side · Screen every company in Blank Checks ↗